Characterizing the immune checkpoint marker profiles of cutaneous squamous cell carcinomas in patients with hidradenitis suppurativa
J Eur Acad Dermatol Venereol
.
2023 Mar;37(3):e316-e318.
doi: 10.1111/jdv.18598.
Epub 2022 Oct 1.
Authors
Franklin R Blum
1
,
J Alex Miles
2
,
Sherif W Farag
3
,
Emma F Johnson
4
,
Mark Davis
4
,
Iltefat H Hamzavi
5
,
Alexis B Lyons
5
,
Christopher J Sayed
2
,
Paul B Googe
2
3
6
Affiliations
1
UNC Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
2
Department of Dermatology, UNC Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
3
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
4
Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
5
Henry Ford Hospital, Department of Dermatology, Detroit, Michigan, USA.
6
UNC Department of Pathology and Laboratory Medicine, Chapel Hill, North Carolina, USA.
PMID:
36151986
DOI:
10.1111/jdv.18598
No abstract available
Publication types
Letter
MeSH terms
Biomarkers
Carcinoma, Squamous Cell* / pathology
Hidradenitis Suppurativa* / complications
Hidradenitis Suppurativa* / pathology
Humans
Skin Neoplasms* / pathology
Substances
Biomarkers